Who Supplies Mebendazole? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Mebendazole exports, with 259+ registered manufacturers shipping to buyers across 108+ countries — yet a handful of companies dominate the shipments. KROSYL PHARMACEUTICALS PRIVATE LIMITED holds the largest share at 19.5% (export value: $2.7M). Close behind, CADILA PHARMACEUTICALS LIMITED (12.3%, $1.7M). LINCOLN PHARMACEUTICALS LTD (8.3%, $1.1M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Mebendazole? Top Manufacturers & Their Buyers
Flow of Mebendazole from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Mebendazole Supplier Network — Key Market Intelligence
The Mebendazole export market from India is led by KROSYL PHARMACEUTICALS PRIVATE LIMITED, which alone commands a 19.5% share, shipping $2.7M worth of product across 3 shipments. The second-largest exporter, CADILA PHARMACEUTICALS LIMITED, contributes $1.7M (12.3%) to the overall market. Combined, the top two suppliers alone account for 31.8% of all Mebendazole exports, indicating a relatively concentrated supply base.
Across all 259 tracked manufacturers, the total Mebendazole export value stands at $13.7M from 2.9K shipments. The market average shipment value is $4.7K. The single largest buyer relationship in terms of trade value is PLANET PHARMA, receiving $1.1M worth of product.
The combined buyer network spans 11 named purchasing companies, including RANBAXY PHARMACEUTICALS PTY LIMITED, EURIMEX PHARMA, SUNSHINE HEALTHCARE LANKA LIMITED, INTERPHARMA INDUSTRIES LIMITED, PLANET PHARMA and 6 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1KROSYL PHARMACEUTICALS PRIVATE LIMITED
KROSYL PHARMACEUTICALS PRIVATE LIMITED is the first-largest Mebendazole exporter from India, with a market share of 19.5% and a total export value of $2.7M across 3 shipments. Their average shipment value of $894.6K is above the market average of $4.7K, suggesting premium or bulk contract pricing.
KROSYL PHARMACEUTICALS PRIVATE LIMITED serves 1 named buyer in our database. TO THE ORDER (CAMERO is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TO THE ORDER (CAMERO — $2.7M across 3 shipments (100.0% of this supplier's total exports)
Key Insight: KROSYL PHARMACEUTICALS PRIVATE LIMITED's per-shipment value of $894.6K is 18991% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.
2CADILA PHARMACEUTICALS LIMITED
CADILA PHARMACEUTICALS LIMITED is the second-largest Mebendazole exporter from India, with a market share of 12.3% and a total export value of $1.7M across 111 shipments. Their average shipment value of $15.2K is above the market average of $4.7K, suggesting premium or bulk contract pricing.
CADILA PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• RANBAXY PHARMACEUTICALS PTY LIMITED — $552.8K across 36 shipments (32.8% of this supplier's total exports)
• EURIMEX PHARMA — $492.6K across 32 shipments (29.3% of this supplier's total exports)
• SUNSHINE HEALTHCARE LANKA LIMITED — $239.7K across 16 shipments (14.2% of this supplier's total exports)
• EURIMEX PHARMA — $201.9K across 13 shipments (12.0% of this supplier's total exports)
• INTERPHARMA INDUSTRIES LIMITED — $196.3K across 13 shipments (11.7% of this supplier's total exports)
Key Insight: CADILA PHARMACEUTICALS LIMITED's per-shipment value of $15.2K is 224% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.
3LINCOLN PHARMACEUTICALS LTD
LINCOLN PHARMACEUTICALS LTD is the third-largest Mebendazole exporter from India, with a market share of 8.3% and a total export value of $1.1M across 22 shipments. Their average shipment value of $51.8K is above the market average of $4.7K, suggesting premium or bulk contract pricing.
LINCOLN PHARMACEUTICALS LTD serves 1 named buyer in our database. PLANET PHARMA is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• PLANET PHARMA — $1.1M across 22 shipments (100.0% of this supplier's total exports)
Key Insight: LINCOLN PHARMACEUTICALS LTD's per-shipment value of $51.8K is 1005% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.
4J B CHEMICALS AND PHARMACEUTICALS LIMITED
J B CHEMICALS AND PHARMACEUTICALS LIMITED is the fourth-largest Mebendazole exporter from India, with a market share of 2.0% and a total export value of $275.3K across 94 shipments. Their average shipment value of $2.9K is below the market average of $4.7K, reflecting a high-volume, competitive pricing strategy.
J B CHEMICALS AND PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• INOVA PHARMACEUTICALS(AUSTRALIA) PT — $94.1K across 32 shipments (34.2% of this supplier's total exports)
• Y LIMITED 5 MILLNER — $77.2K across 26 shipments (28.0% of this supplier's total exports)
• INOVA PHARMACEUTICALS(AUSTRALIA) PT — $51.8K across 18 shipments (18.8% of this supplier's total exports)
• MERCYMED TRADING PLC — $33.2K across 11 shipments (12.1% of this supplier's total exports)
• AL-HAITHAM CHEMICALS — $19.0K across 6 shipments (6.9% of this supplier's total exports)
Key Insight: J B CHEMICALS AND PHARMACEUTICALS LIMITED operates with high shipment frequency (94 shipments) at a per-shipment value of $2.9K, indicating a broad distribution network with many smaller, regular orders.
5PRASHI PHARMA PRIVATE LIMITED
PRASHI PHARMA PRIVATE LIMITED is the fifth-largest Mebendazole exporter from India, with a market share of 1.5% and a total export value of $205.1K across 32 shipments. Their average shipment value of $6.4K is above the market average of $4.7K, suggesting premium or bulk contract pricing.
PRASHI PHARMA PRIVATE LIMITED serves 1 named buyer in our database. STE PRINCE PHARMA SARL is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• STE PRINCE PHARMA SARL — $205.1K across 32 shipments (100.0% of this supplier's total exports)
Key Insight: PRASHI PHARMA PRIVATE LIMITED's per-shipment value of $6.4K is 37% above the market average of $4.7K, consistent with large-order contracts or value-added formulations.
6BEID HEALTHCARE PRIVATE LIMITED
BEID HEALTHCARE PRIVATE LIMITED is the fifth-largest Mebendazole exporter from India, with a market share of 0.3% and a total export value of $39.0K across 40 shipments. Their average shipment value of $976 is below the market average of $4.7K, reflecting a high-volume, competitive pricing strategy.
BEID HEALTHCARE PRIVATE LIMITED serves 1 named buyer in our database. CONSULTING PHARMA FORMULATIONS (CPF is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• CONSULTING PHARMA FORMULATIONS (CPF — $39.0K across 40 shipments (100.0% of this supplier's total exports)
Key Insight: BEID HEALTHCARE PRIVATE LIMITED operates with high shipment frequency (40 shipments) at a per-shipment value of $976, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Mebendazole Flows
Once Mebendazole leaves the manufacturing plants of companies like KROSYL PHARMACEUTICALS PRIVATE LIMITED and CADILA PHARMACEUTICALS LIMITED, it travels to 5 destination markets with a combined import value of $13.7M. Cameroon absorbs the largest share at 22.4% ($3.1M), followed by France (14.3%) and South Africa (8.8%).
This geographic spread reflects Mebendazole's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Mebendazole Go? Top Importing Countries & Their Buyers
Trade flow of Mebendazole exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Cameroon
Cameroon ranks as the first-largest destination for Mebendazole imports from India, with a total trade value of $3.1M across 0 shipments — representing a 22.4% share of all Mebendazole exports. The average shipment value of $3.1M is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations.
Key Insight: Cameroon's per-shipment average of $3.1M (65588% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Cameroon is a key market for Mebendazole imports from India.
2France
France ranks as the second-largest destination for Mebendazole imports from India, with a total trade value of $2.0M across 52 shipments — representing a 14.3% share of all Mebendazole exports. The average shipment value of $37.9K is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Mebendazole importers in France: PLANET PHARMA is the largest buyer, accounting for 61.9% ($1.2M) of this market's total imports.
• PLANET PHARMA — $1.2M (61.9% of France's total)
• EURIMEX PHARMA — $492.6K (25.0% of France's total)
• EURIMEX PHARMA. — $201.9K (10.3% of France's total)
Key Insight: France's per-shipment average of $37.9K (708% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Mebendazole imports from India.
3South Africa
South Africa ranks as the third-largest destination for Mebendazole imports from India, with a total trade value of $1.2M across 35 shipments — representing a 8.8% share of all Mebendazole exports. The average shipment value of $34.5K is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Mebendazole importers in South Africa: RANBAXY PHARMACEUTICALS (PTY) LTD. is the largest buyer, accounting for 45.7% ($552.8K) of this market's total imports.
• RANBAXY PHARMACEUTICALS (PTY) LTD. — $552.8K (45.7% of South Africa's total)
• RANBAXY PHARMACEUTICALS PTY LTD — $323.9K (26.8% of South Africa's total)
• RANBAXY PHARMACEUTICALS (PTY) LTD — $169.0K (14.0% of South Africa's total)
Key Insight: South Africa's per-shipment average of $34.5K (637% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Africa is a key market for Mebendazole imports from India.
4Sri Lanka
Sri Lanka ranks as the fourth-largest destination for Mebendazole imports from India, with a total trade value of $717.0K across 14 shipments — representing a 5.2% share of all Mebendazole exports. The average shipment value of $51.2K is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Mebendazole importers in Sri Lanka: SUNSHINE HEALTHCARE LANKA LIMITED is the largest buyer, accounting for 34.5% ($247.5K) of this market's total imports.
• SUNSHINE HEALTHCARE LANKA LIMITED — $247.5K (34.5% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $51.2K (993% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Mebendazole imports from India.
5Congo Dr
Congo Dr ranks as the fifth-largest destination for Mebendazole imports from India, with a total trade value of $679.9K across 42 shipments — representing a 4.9% share of all Mebendazole exports. The average shipment value of $16.2K is above the global average of $4.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Mebendazole importers in Congo Dr: STE PRINCE PHARMA SARL is the largest buyer, accounting for 66.5% ($452.0K) of this market's total imports.
• STE PRINCE PHARMA SARL — $452.0K (66.5% of Congo Dr's total)
Key Insight: Congo Dr's per-shipment average of $16.2K (245% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Congo Dr is a key market for Mebendazole imports from India.
People Also Ask — Mebendazole Supplier & Trade Network
Who are the top suppliers of Mebendazole from India?+
Which companies buy Mebendazole from Indian manufacturers?+
Where does Mebendazole exported from India go?+
What is the market share of the top Mebendazole supplier from India?+
What is the average shipment value for Mebendazole exports from India?+
Is Mebendazole manufactured in India and exported globally?+
Which country imports the most Mebendazole from India?+
Who are the buyers of Mebendazole in France?+
How concentrated is the Mebendazole supplier market in India?+
How do I find verified buyers for Mebendazole in specific countries?+
Mebendazole Trade Network — Key Takeaways
- 1KROSYL PHARMACEUTICALS PRIVATE LIMITED is India's dominant Mebendazole exporter with a 19.5% market share and $2.7M in total exports — making it the single most important sourcing entity in this market.
- 2The top 259 suppliers collectively account for 43.9% of all tracked Mebendazole exports, with a combined trade value of $13.7M.
- 3Cameroon is the largest destination market, absorbing 22.4% of India's Mebendazole exports ($3.1M). France (14.3%) and South Africa (8.8%) follow.
- 4With 2.9K total shipments averaging $4.7K each, the Mebendazole export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include RANBAXY PHARMACEUTICALS PTY LIMITED, EURIMEX PHARMA, PLANET PHARMA, INOVA PHARMACEUTICALS(AUSTRALIA) PT — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 1 customers
6 suppliers → 108 countries
Network value: $13.7M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Mebendazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Mebendazole.
- 2.Flow Mapping: 259 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,932 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 108 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,932 Verified Shipments
259 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists